Key facts
- Novus Diagnostics Ltd. filed SCHEDULE 13G for TRINITY BIOTECH PLC @Class 'A' Ordinary Shares represented by American Depositary Shares (TRIB).
- Disclosed ownership: 6%.
- Date of event: 23 Dec 2025.
Novus Diagnostics Ltd. - 23 Dec 2025 SCHEDULE 13G Report for TRINITY BIOTECH PLC @Class 'A' Ordinary Shares represented by American Depositary Shares (TRIB)
- Filing Manager
- Novus Diagnostics Ltd.
- Reporting Manager
- Novus Diagnostics Ltd.
- Symbol
- TRIB
- Shares outstanding
- 18,697,629 shares
- Disclosed Ownership
- 1,119,988 shares
- Ownership
- 6%
- Form type
- SCHEDULE 13G
- Filing time
- 06 Mar 2026, 17:01:08 UTC
- Date of event
- 23 Dec 2025
- SEC
- View on sec.gov
Key filing fact
Novus Diagnostics Ltd. disclosed 6% ownership in TRINITY BIOTECH PLC @Class 'A' Ordinary Shares represented by American Depositary Shares (TRIB) on 23 Dec 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 06 Mar 2026, 17:01.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Novus Diagnostics Ltd. | 6% | 1,119,988 | 1,119,988 | 0 | /s/ Keith O'Neill | Keith O'Neill/Chief Executive Officer |
CIK / CUSIP context first